Functional imaging reveals cerebral microvascular dysfunction in primary antiphospholipid syndrome: Pathophysiologic
A Mameli1, L Indovina2, F Cocciolillo3
1Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Journal of the Neurological Sciences
|January 13, 2026
Summary
Primary antiphospholipid syndrome (PAPS) causes brain hypoperfusion in frontoparietal regions, even without visible lesions. This functional imaging study reveals subclinical brain changes in PAPS patients.
Area of Science:
- Neuroimmunology
- Vascular Neurology
- Rheumatology
Background:
- Primary antiphospholipid syndrome (PAPS) is an autoimmune disorder causing thrombosis and antiphospholipid antibodies (aPL).
- PAPS is increasingly linked to neuropsychiatric symptoms, often without clear ischemic damage on conventional imaging.
- Subtle cerebral dysfunction may underlie cognitive and mood disturbances in PAPS patients.
Purpose of the Study:
- To investigate cerebral blood flow patterns in well-defined PAPS patients using functional neuroimaging.
- To identify potential subclinical neurovascular abnormalities associated with PAPS.
- To explore the relationship between cerebral hypoperfusion and neuropsychiatric symptoms in PAPS.
Main Methods:
- Brain single-photon emission computed tomography (SPECT) was performed on 25 PAPS patients and age/sex-matched controls.
- Statistical Parametric Mapping (SPM) analysis was used to compare cerebral perfusion between groups.
- Results were analyzed independently of clinical neurological status and MRI findings.
Main Results:
- PAPS patients exhibited significantly reduced cerebral perfusion in bilateral frontoparietal cortices compared to controls.
- This pattern of hypoperfusion was consistent across PAPS patients, irrespective of neurological symptoms or MRI data.
- Findings suggest functional microvascular impairment and neuroinflammation contribute to cerebral dysfunction in PAPS.
Conclusions:
- Functional SPECT imaging reveals subclinical cerebral hypoperfusion in PAPS, indicating microvascular dysfunction beyond thrombosis.
- These findings support a neuroimmunological basis for neuropsychiatric symptoms in PAPS, involving endothelial dysfunction and neuroinflammation.
- Early detection of these functional changes may enable timely therapeutic interventions to prevent neuronal damage.
Keywords:
99Tc-ECD-SPECTCentral nervous systemEndothelial activationMicrovascular disfunctionNeuroimmunologyPrimary antiphospholipid syndrome (PAPS)Regional cerebral blood flowStatistical parametric mapping

